What is Eurepa tablet?
Eurepa 1 Tablet is used to lower blood sugar levels in adults with type 2 diabetes mellitus. It is usually prescribed along with other diabetes medicines to achieve adequate blood sugar control. It also prevents serious complications of diabetes like kidney damage and blindness.
Can I take repaglinide after eating?
You must take this medication with your meal. You may take it 15 minutes before a meal to 15 minutes after a meal. Many people take it with the first bite of the meal. If you take this medication you must eat.
What time should I take repaglinide?
This medicine usually is taken 15 minutes before a meal but may be taken up to 30 minutes before a meal.
What is the use of repaglinide tablets?
Repaglinide is used to treat type 2 diabetes (condition in which the body does not use insulin normally and, therefore, cannot control the amount of sugar in the blood). Repaglinide helps your body regulate the amount of glucose (sugar) in your blood.
When should I take Eurepa?
Quick tips
- For best results, take Eurepa 1 Tablet 15 to 30 minutes before a meal.
- You should continue to exercise regularly, eat a healthy diet, and take your other diabetes medicines along with Eurepa 1 Tablet.
- It may cause dizziness.
What are the side effects of repaglinide?
Incidence not known
- Back, leg, or stomach pains.
- blistering, peeling, or loosening of the skin.
- darkened urine.
- difficulty with breathing.
- general body swelling.
- general tiredness and weakness.
- indigestion.
- itching or rash.
How many hours does repaglinide last?
Repaglinide peak plasma levels occur within 1 hour, and the plasma half-life is 1 hour. It is recommended that this drug be taken just before each meal. Nateglinide is most effective if taken 1 to 10 minutes before a meal. These drugs offer the advantage of rapid and short-term control over blood glucose.
How much repaglinide should I take?
Adults—0.5 to 4 milligrams (mg) before each meal. Your doctor may increase your dose as needed. However, the dose is usually not more than 16 mg per day. Children—Use and dose must be determined by your doctor.
What class of drug is repaglinide?
Repaglinide is a drug used in the treatment of diabetes mellitus type 2. It belongs to a class of antihyperglycemic agents known as meglitinides, along with nateglinide. Meglitinides work to reduce blood glucose levels by stimulating endogenous insulin production.
How many times a day can you take repaglinide?
Adults—The dose should be individualized starting at 1 milligram (mg) repaglinide and 500 mg metformin combination 2 times a day. Your doctor may increase your dose as needed to control your blood sugar up to a maximum of 10 mg repaglinide and 2500 mg metformin combination per day, divided into 2 or 3 doses.
How long does repaglinide last?
Repaglinide starts to work in 30 minutes to an hour. Its effect lasts for a few hours.
What happens if you take too much repaglinide?
Under certain conditions, too much metformin and repaglinide can cause lactic acidosis. Symptoms of lactic acidosis are severe and quick to appear and usually occur when other health problems not related to the medicine are present and are very severe, such as a heart attack or kidney failure.
How long does it take repaglinide to work?
Repaglinide starts to work in 30 minutes to an hour. Its effect lasts for a few hours. Can repaglinide cause hypoglycemia? Repaglinide can cause low blood sugar (hypoglycemia).
Is repaglinide better than metformin?
CONCLUSIONS—Combined with bedtime NPH insulin, metformin provides superior glycemic control to repaglinide with less weight gain and improved diabetes treatment satisfaction.
Which is better glimepiride or repaglinide?
Conclusion. Repaglinide treatment is more beneficial than glimepiride for decreasing glucose variability in patients with type 2 diabetes. These smaller glucose fluctuations are associated with decreased levels of inflammation and oxidative stress markers.
How long does it take for repaglinide to work?
How much does repaglinide lower A1C?
Studies examining the use of repaglinide as monotherapy have shown A1C reductions up to 2.3% with fasting and postprandial reductions of 3.9 mmol/L and 6.4 mmol/L respectively.